Journal of Functional Foods (Apr 2024)
Anti-obesity effects of Bifidobacterium lactis YGMCC2013 by promoting adipocyte thermogenesis and beige remodelling in association with gut microbiota
Abstract
Obesity, a global public health challenge, is closely associated with gut microbiota alterations. Probiotics have the potential to prevent obesity, but their effectiveness can vary depending on the specific strain. This study focused on evaluating the anti-obesity and probiotic properties of four Bifidobacterium species isolated from healthy Chinese individuals in vitro. The findings indicated that Bifidobacterium lactis YGMCC2013 showed notable cholesterol assimilation ability, bile salt hydrolase activity, gastrointestinal tolerance, cellular adhesion, and production of short-chain fatty acids. The anti-obesity effect of YGMCC2013 was then assessed in mice fed a high-fat diet. The results demonstrated that YGMCC2013 reduced body and liver weight, adipose tissue hypertrophy and inflammation, and influenced specific microbial genera associated with adipose tissue characteristics. Notably, the study observed associations between certain microbial genera and different types of adipose tissue, indicating that YGMCC2013 may impact the balance and function of adipose tissue through its effects on the gut microbiota. Furthermore, YGMCC2013 enhanced the thermogenic capacity of brown and beige adipocytes, and improved the structure and function of the gut microbiota. These improvements were reflected by an increase in short-chain fatty acids produced by beneficial bacteria in the intestine, and the activation of metabolic pathways related to energy and carbohydrate metabolism. Moreover, YGMCC2013 modulated the expression of il-27 and tgr5 signaling pathways in adipose tissue, which might be involved in regulating adipose tissue inflammation and energy expenditure, respectively. These findings collectively demonstrate that YGMCC2013 has potential as a probiotic candidate for preventing obesity and improving metabolic health by influencing the gut-adipose tissue axis.